




Instance: composition-en-d95102bde9e6478e73d009f96eccf149
InstanceOf: CompositionUvEpi
Title: "Composition for levodopacarbidopaentacapone Package Leaflet"
Description:  "Composition for levodopacarbidopaentacapone Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "EU/1/11/706/001-006"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mpd95102bde9e6478e73d009f96eccf149)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - levodopacarbidopaentacapone"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional

  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  
  </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet:</p>
<ol type="1">
<li>What Levodopa/Carbidopa/Entacapone Orion is and what it is used
for</li>
<li>What you need to know before you take Levodopa/Carbidopa/Entacapone
Orion</li>
<li>How to take Levodopa/Carbidopa/Entacapone Orion</li>
<li>Possible side effects</li>
<li>How to store Levodopa/Carbidopa/Entacapone Orion</li>
<li>Contents of the pack and other information</li>
</ol>
 </div>"""   
          

* section[=].section[+]
  * title =  "1. What levodopacarbidopaentacapone is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What levodopacarbidopaentacapone is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Levodopa/Carbidopa/Entacapone Orion contains three active substances
(levodopa, carbidopa and entacapone) in one film-coated tablet.
Levodopa/Carbidopa/Entacapone Orion is used for the treatment of
Parkinson s disease. Parkinson s disease is caused by low levels of a
substance called dopamine in the brain. Levodopa increases the amount of
dopamine and hence reduces the symptoms of Parkinson s disease.
Carbidopa and entacapone improve the antiparkinson effects of
levodopa.</p>
 </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take levodopacarbidopaentacapone"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take levodopacarbidopaentacapone"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <h2 id="do-not-take-levodopacarbidopaentacapone-orion-if-you">Do not
take Levodopa/Carbidopa/Entacapone Orion if you:</h2>
<h2
id="are-allergic-to-levodopa-carbidopa-or-entacapone-or-any-of-the-other-ingredients-of-this-medicine-listed-in-section-6">are
allergic to levodopa, carbidopa or entacapone, or any of the other
ingredients of this medicine (listed in section 6)</h2>
<h2 id="have-narrow-angle-glaucoma-an-eye-disorder">have narrow-angle
glaucoma (an eye disorder)</h2>
<h2 id="have-a-tumour-of-the-adrenal-gland">have a tumour of the adrenal
gland</h2>
<h2
id="are-taking-certain-medicines-for-treating-depression-combinations-of-selective-mao-a-and-mao-b-inhibitors-or-non-selective-mao-inhibitors">are
taking certain medicines for treating depression (combinations of
selective MAO-A and MAO-B inhibitors, or non-selective
MAO-inhibitors)</h2>
<h2
id="have-ever-had-neuroleptic-malignant-syndrome-nms-this-is-a-rare-reaction-to-medicines-used-to-treat-severe-mental-disorders">have
ever had neuroleptic malignant syndrome (NMS this is a rare reaction to
medicines used to treat severe mental disorders)</h2>
<h2
id="have-ever-had-non-traumatic-rhabdomyolysis-a-rare-muscle-disorder">have
ever had non-traumatic rhabdomyolysis (a rare muscle disorder)</h2>
<h2
id="have-a-severe-liver-disease-warnings-and-precautions-talk-to-your-doctor-or-pharmacist-before-taking-levodopacarbidopaentacapone-orion-if-you-have-or-have-ever-had">have
a severe liver disease. Warnings and precautions Talk to your doctor or
pharmacist before taking Levodopa/Carbidopa/Entacapone Orion if you have
or have ever had:</h2>
<h2
id="a-heart-attack-or-any-other-diseases-of-the-heart-including-cardiac-arrhythmias-or-of-the-blood-vessels">a
heart attack or any other diseases of the heart including cardiac
arrhythmias, or of the blood vessels</h2>
<h2 id="asthma-or-any-other-disease-of-the-lungs">asthma or any other
disease of the lungs</h2>
<h2 id="a-liver-problem-because-your-dose-may-need-to-be-adjusted">a
liver problem, because your dose may need to be adjusted</h2>
<h2 id="kidney-or-hormone-related-diseases">kidney or hormone-related
diseases</h2>
<h2 id="stomach-ulcers-or-convulsions">stomach ulcers or
convulsions</h2>
<h2
id="if-you-experience-prolonged-diarrhoea-consult-your-doctor-as-it-may-be-a-sign-of-inflammation-of-the-colon">if
you experience prolonged diarrhoea consult your doctor as it may be a
sign of inflammation of the colon</h2>
<h2 id="any-form-of-severe-mental-disorder-like-psychosis">any form of
severe mental disorder like psychosis</h2>
<h2
id="chronic-wide-angle-glaucoma-because-your-dose-may-need-to-be-adjusted-and-the-pressure-in-your-eyes-may-need-to-be-monitored-consult-your-doctor-if-you-are-currently-taking">chronic
wide-angle glaucoma, because your dose may need to be adjusted and the
pressure in your eyes may need to be monitored. Consult your doctor if
you are currently taking:</h2>
<h2 id="antipsychotics-medicines-used-to-treat-psychosis">antipsychotics
(medicines used to treat psychosis)</h2>
<h2
id="a-medicine-which-may-cause-low-blood-pressure-when-rising-from-a-chair-or-bed-you-should-be-aware-that-levodopacarbidopaentacapone-orion-may-make-these-reactions-worse-consult-your-doctor-if-during-the-treatment-with-levodopacarbidopaentacapone-orion-you">a
medicine which may cause low blood pressure when rising from a chair or
bed. You should be aware that Levodopa/Carbidopa/Entacapone Orion may
make these reactions worse. Consult your doctor if during the treatment
with Levodopa/Carbidopa/Entacapone Orion you:</h2>
<h2
id="notice-that-your-muscles-get-very-rigid-or-jerk-violently-or-if-you-get-tremors-agitation-confusion-fever-rapid-pulse-or-wide-fluctuations-in-your-blood-pressure-if-any-of-this-happens-contact-your-doctor-immediately">notice
that your muscles get very rigid or jerk violently, or if you get
tremors, agitation, confusion, fever, rapid pulse, or wide fluctuations
in your blood pressure. If any of this happens, contact your doctor
immediately.</h2>
<h2
id="feel-depressed-have-suicidal-thoughts-or-notice-unusual-changes-in-your-behaviour">feel
depressed, have suicidal thoughts, or notice unusual changes in your
behaviour</h2>
<h2
id="find-yourself-suddenly-falling-asleep-or-if-you-feel-very-drowsy-if-this-happens-you-should-not-drive-or-use-any-tools-or-machines-see-also-section-driving-and-using-machines-">find
yourself suddenly falling asleep, or if you feel very drowsy. If this
happens, you should not drive or use any tools or machines (see also
section Driving and using machines ).</h2>
<h2
id="notice-that-uncontrolled-movements-begin-or-get-worse-after-you-started-to-take-levodopacarbidopaentacapone-orion-if-this-happens-your-doctor-may-need-to-change-the-dose-of-your-antiparkinson-medicine">notice
that uncontrolled movements begin or get worse after you started to take
Levodopa/Carbidopa/Entacapone Orion. If this happens, your doctor may
need to change the dose of your antiparkinson medicine.</h2>
<h2
id="experience-diarrhoea-monitoring-of-your-weight-is-recommended-in-order-to-avoid-potentially-excessive-weight-loss">experience
diarrhoea: monitoring of your weight is recommended in order to avoid
potentially excessive weight loss</h2>
<h2
id="experience-progressive-anorexia-asthenia-weakness-exhaustion-and-weight-decrease-within-a-relatively-short-period-of-time-if-this-happens-a-general-medical-evaluation-including-liver-function-should-be-considered">experience
progressive anorexia, asthenia (weakness, exhaustion) and weight
decrease within a relatively short period of time. If this happens, a
general medical evaluation including liver function should be
considered.</h2>
<h2
id="feel-the-need-to-stop-using-levodopacarbidopaentacapone-orion-see-section-if-you-stop-taking-levodopacarbidopaentacapone-orion--tell-your-doctor-if-you-or-your-familycarer-notices-you-are-developing-addiction-like-symptoms-leading-to-craving-for-large-doses-of-levodopacarbidopaentacapone-orion-and-other-medicines-used-to-treat-parkinson-s-disease-tell-your-doctor-if-you-or-your-familycarer-notices-you-are-developing-urges-or-cravings-to-behave-in-ways-that-are-unusual-for-you-or-you-cannot-resist-the-impulse-drive-or-temptation-to-carry-out-certain-activities-that-could-harm-yourself-or-others-these-behaviours-are-called-impulse-control-disorders-and-can-include-addictive-gambling-excessive-eating-or-spending-an-abnormally-high-sex-drive-or-a-preoccupation-with-an-increase-in-sexual-thoughts-or-feelings-your-doctor-may-need-to-review-your-treatments-your-doctor-may-take-some-regular-laboratory-tests-during-a-long-term-treatment-with-levodopacarbidopaentacapone-orion-if-you-must-undergo-surgery-please-tell-your-doctor-that-you-are-using-levodopacarbidopaentacapone-orion-levodopacarbidopaentacapone-orion-is-not-recommended-to-be-used-for-treatment-of-extrapyramidal-symptoms-eg-involuntary-movements-shaking-muscle-rigidity-and-muscle-contractions-caused-by-other-medicines-children-and-adolescents-experience-with-levodopacarbidopaentacapone-orion-in-patients-under-18-years-is-limited-therefore-the-use-of-levodopacarbidopaentacapone-orion-in-children-or-adolescents-is-not-recommended-other-medicines-and-levodopacarbidopaentacapone-orion-tell-your-doctor-or-pharmacist-if-you-are-taking-have-recently-taken-or-might-take-any-other-medicines-do-not-take-levodopacarbidopaentacapone-orion-if-you-are-taking-certain-medicines-for-treating-depression-combinations-of-selective-mao-a-and-mao-b-inhibitors-or-non-selective-mao-inhibitors-levodopacarbidopaentacapone-orion-may-increase-the-effects-and-side-effects-of-certain-medicines-these-include">feel
the need to stop using Levodopa/Carbidopa/Entacapone Orion, see section
If you stop taking Levodopa/Carbidopa/Entacapone Orion . Tell your
doctor if you or your family/carer notices you are developing
addiction-like symptoms leading to craving for large doses of
Levodopa/Carbidopa/Entacapone Orion and other medicines used to treat
Parkinson s disease. Tell your doctor if you or your family/carer
notices you are developing urges or cravings to behave in ways that are
unusual for you or you cannot resist the impulse, drive or temptation to
carry out certain activities that could harm yourself or others. These
behaviours are called impulse control disorders and can include
addictive gambling, excessive eating or spending, an abnormally high sex
drive or a preoccupation with an increase in sexual thoughts or
feelings. Your doctor may need to review your treatments. Your doctor
may take some regular laboratory tests during a long term treatment with
Levodopa/Carbidopa/Entacapone Orion. If you must undergo surgery, please
tell your doctor that you are using Levodopa/Carbidopa/Entacapone Orion.
Levodopa/Carbidopa/Entacapone Orion is not recommended to be used for
treatment of extrapyramidal symptoms (e.g. involuntary movements,
shaking, muscle rigidity and muscle contractions) caused by other
medicines. Children and adolescents Experience with
Levodopa/Carbidopa/Entacapone Orion in patients under 18 years is
limited. Therefore, the use of Levodopa/Carbidopa/Entacapone Orion in
children or adolescents is not recommended. Other medicines and
Levodopa/Carbidopa/Entacapone Orion Tell your doctor or pharmacist if
you are taking, have recently taken or might take any other medicines.
Do not take Levodopa/Carbidopa/Entacapone Orion if you are taking
certain medicines for treating depression (combinations of selective
MAO-A and MAO-B inhibitors, or non-selective MAO inhibitors).
Levodopa/Carbidopa/Entacapone Orion may increase the effects and side
effects of certain medicines. These include:</h2>
<h2
id="medicines-used-to-treat-depression-such-as-moclobemide-amitriptyline-desipramine-maprotiline-venlafaxine-and-paroxetine">medicines
used to treat depression such as moclobemide, amitriptyline,
desipramine, maprotiline, venlafaxine and paroxetine</h2>
<h2
id="rimiterole-and-isoprenaline-used-to-treat-respiratory-diseases">rimiterole
and isoprenaline, used to treat respiratory diseases</h2>
<h2 id="adrenaline-used-for-severe-allergic-reactions">adrenaline, used
for severe allergic reactions</h2>
<h2
id="noradrenaline-dopamine-and-dobutamine-used-to-treat-heart-diseases-and-low-blood-pressure">noradrenaline,
dopamine and dobutamine, used to treat heart diseases and low blood
pressure</h2>
<h2
id="alpha-methyldopa-used-to-treat-high-blood-pressure">alpha-methyldopa,
used to treat high blood pressure</h2>
<h2
id="apomorphine-which-is-used-to-treat-parkinson-s-disease-the-effects-of-levodopacarbidopaentacapone-orion-may-be-weakened-by-certain-medicines-these-include">apomorphine,
which is used to treat Parkinson s disease. The effects of
Levodopa/Carbidopa/Entacapone Orion may be weakened by certain
medicines. These include:</h2>
<h2
id="dopamine-antagonists-used-to-treat-mental-disorders-nausea-and-vomiting">dopamine
antagonists used to treat mental disorders, nausea and vomiting</h2>
<h2 id="phenytoin-used-to-prevent-convulsions">phenytoin, used to
prevent convulsions</h2>
<p>papaverine used to relax the muscles. Levodopa/Carbidopa/Entacapone
Orion may make it harder for you to digest iron. Therefore, do not take
Levodopa/Carbidopa/Entacapone Orion and iron supplements at the same
time. After taking one of them, wait at least 2 to 3 hours before taking
the other. Levodopa/Carbidopa/Entacapone Orion with food and drink
Levodopa/Carbidopa/Entacapone Orion may be taken with or without food.
For some patients, Levodopa/Carbidopa/Entacapone Orion may not be well
absorbed if it is taken with, or shortly after eating protein-rich food
(such as meats, fish, dairy products, seeds and nuts). Consult your
doctor if you think this applies to you. Pregnancy, breast-feeding and
fertility If you are pregnant or breast-feeding, think you may be
pregnant or are planning to have a baby, ask your doctor or pharmacist
for advice before taking this medicine. You should not breast-feed
during treatment with Levodopa/Carbidopa/Entacapone Orion. Driving and
using machines Levodopa/Carbidopa/Entacapone Orion may lower your blood
pressure, which may make you feel light-headed or dizzy. Therefore, be
particularly careful when you drive or when you use any tools or
machines. If you feel very drowsy, or if you sometimes find yourself
suddenly falling asleep, wait until you feel fully awake again before
driving or doing anything else that requires you to be alert. Otherwise,
you may put yourself and others at risk of serious injury or death.
Levodopa/Carbidopa/Entacapone Orion contains sucrose
Levodopa/Carbidopa/Entacapone Orion contains sucrose (1.2 mg/tablet). If
you have been told by your doctor that you have intolerance to some
sugars, contact your doctor before taking this medicinal product. This
medicine contains less than 1 mmol (23 mg) sodium per maximum
recommended daily dose, that is to say essentially sodium-free .</p>
 </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take levodopacarbidopaentacapone"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take levodopacarbidopaentacapone"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <h2
id="always-take-this-medicine-exactly-as-your-doctor-or-pharmacist-has-told-you-check-with-your-doctor-or-pharmacist-if-you-are-not-sure-for-adults-and-elderly">Always
take this medicine exactly as your doctor or pharmacist has told you.
Check with your doctor or pharmacist if you are not sure. For adults and
elderly:</h2>
<h2
id="your-doctor-will-tell-you-exactly-how-many-tablets-of-levodopacarbidopaentacapone-orion-to-take-each-day">Your
doctor will tell you exactly how many tablets of
Levodopa/Carbidopa/Entacapone Orion to take each day.</h2>
<h2
id="the-tablets-are-not-intended-to-be-split-or-broken-into-smaller-pieces">The
tablets are not intended to be split or broken into smaller pieces.</h2>
<h2 id="you-should-take-only-one-tablet-each-time">You should take only
one tablet each time.</h2>
<h2
id="depending-on-how-you-respond-to-treatment-your-doctor-may-suggest-a-higher-or-lower-dose">Depending
on how you respond to treatment, your doctor may suggest a higher or
lower dose.</h2>
<p>If you are taking Levodopa/Carbidopa/Entacapone Orion 50 mg/12.5
mg/200 mg, 75 mg/18.75 mg/200 mg, 100 mg/25 mg/200 mg, 125 mg/31.25
mg/200 mg or 150 mg/37.5 mg/200 mg tablets, do not take more than 10
tablets per day. Talk to your doctor or pharmacist if you think the
effect of Levodopa/Carbidopa/Entacapone Orion is too strong or too weak,
or if you experience possible side effects. To open the bottle for the
first time: open the closure, and then press with your thumb on the seal
until it breaks. See picture 1. Picture 1 If you take more
Levodopa/Carbidopa/Entacapone Orion than you should If you have
accidentally taken more Levodopa/Carbidopa/Entacapone Orion tablets than
you should, talk to your doctor or pharmacist immediately. In case of an
overdose you may feel confused or agitated, your heart rate may be
slower or faster than normal or the colour of your skin, tongue, eyes or
urine may change. If you forget to take Levodopa/Carbidopa/Entacapone
Orion Do not take a double dose to make up for a forgotten tablet. If it
is more than 1 hour until your next dose: Take one tablet as soon as you
remember, and the next tablet at the normal time. If it is less than 1
hour until your next dose: Take a tablet as soon as you remember, wait 1
hour, then take another tablet. After that carry on as normal. Always
leave at least an hour between Levodopa/Carbidopa/Entacapone Orion
tablets, to avoid possible side effects. If you stop taking
Levodopa/Carbidopa/Entacapone Orion Do not stop taking
Levodopa/Carbidopa/Entacapone Orion unless your doctor tells you to. In
such a case your doctor may need to adjust your other antiparkinson
medicines, especially levodopa, to give sufficient control of your
symptoms. If you suddenly stop taking Levodopa/Carbidopa/Entacapone
Orion and other antiparkinsonian medicines it may result in unwanted
side effects. If you have any further questions on the use of this
medicine, ask your doctor or pharmacist.</p>
 </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <h2
id="like-all-medicines-this-medicine-can-cause-side-effects-although-not-everybody-gets-them-many-of-the-side-effects-can-be-relieved-by-adjusting-the-dose-if-you-during-the-treatment-with-levodopacarbidopaentacapone-orion-experience-the-following-symptoms-contact-your-doctor-immediately">Like
all medicines, this medicine can cause side effects, although not
everybody gets them. Many of the side effects can be relieved by
adjusting the dose. If you during the treatment with
Levodopa/Carbidopa/Entacapone Orion experience the following symptoms,
contact your doctor immediately:</h2>
<h2
id="your-muscles-get-very-rigid-or-jerk-violently-you-get-tremors-agitation-confusion-fever-rapid-pulse-or-wide-fluctuations-in-your-blood-pressure-these-can-be-symptoms-of-neuroleptic-malignant-syndrome-nms-a-rare-severe-reaction-to-medicines-used-to-treat-disorders-of-the-central-nervous-system-or-rhabdomyolysis-a-rare-severe-muscle-disorder">Your
muscles get very rigid or jerk violently, you get tremors, agitation,
confusion, fever, rapid pulse, or wide fluctuations in your blood
pressure. These can be symptoms of neuroleptic malignant syndrome (NMS,
a rare severe reaction to medicines used to treat disorders of the
central nervous system) or rhabdomyolysis (a rare severe muscle
disorder).</h2>
<h2
id="allergic-reaction-the-signs-may-include-hives-nettle-rash-itching-rash-swelling-of-your-face-lips-tongue-or-throat-this-may-cause-difficulties-in-breathing-or-swallowing-very-common-may-affect-more-than-1-in-10-people">Allergic
reaction, the signs may include hives (nettle rash), itching, rash,
swelling of your face, lips, tongue or throat. This may cause
difficulties in breathing or swallowing. Very common (may affect more
than 1 in 10 people):</h2>
<h2 id="uncontrolled-movements-dyskinesias">uncontrolled movements
(dyskinesias)</h2>
<h2 id="feeling-sick-nausea">feeling sick (nausea)</h2>
<h2 id="harmless-reddish-brown-discolouration-of-urine">harmless
reddish-brown discolouration of urine</h2>
<h2 id="muscle-pain">muscle pain</h2>
<h2 id="diarrhoea-common-may-affect-up-to-1-in-10-people">diarrhoea.
Common (may affect up to 1 in 10 people):</h2>
<h2
id="light-headedness-or-fainting-due-to-low-blood-pressure-high-blood-pressure">light-headedness
or fainting due to low blood pressure, high blood pressure</h2>
<h2
id="worsening-of-parkinson-s-symptoms-dizziness-drowsiness">worsening of
Parkinson s symptoms, dizziness, drowsiness</h2>
<h2
id="vomiting-abdominal-pain-and-discomfort-heartburn-dry-mouth-constipation">vomiting,
abdominal pain and discomfort, heartburn, dry mouth, constipation</h2>
<h2
id="inability-to-sleep-hallucinations-confusion-abnormal-dreams-including-nightmares-tiredness">inability
to sleep, hallucinations, confusion, abnormal dreams (including
nightmares), tiredness</h2>
<h2
id="mental-changes-including-problems-with-memory-anxiety-and-depression-possibly-with-thoughts-of-suicide">mental
changes including problems with memory, anxiety and depression (possibly
with thoughts of suicide)</h2>
<h2
id="heart-or-artery-disease-events-eg-chest-pain-irregular-heart-rate-or-rhythm">heart
or artery disease events (e.g. chest pain), irregular heart rate or
rhythm</h2>
<h2 id="more-frequent-falling">more frequent falling</h2>
<h2 id="shortness-of-breath">shortness of breath</h2>
<h2 id="increased-sweating-rashes">increased sweating, rashes</h2>
<h2 id="muscle-cramps-swelling-of-legs">muscle cramps, swelling of
legs</h2>
<h2 id="blurred-vision">blurred vision</h2>
<h2 id="anaemia">anaemia</h2>
<h2 id="decreased-appetite-decreased-weight">decreased appetite,
decreased weight</h2>
<h2 id="headache-joint-pain">headache, joint pain</h2>
<h2
id="urinary-tract-infection-uncommon-may-affect-up-to-1-in-100-people">urinary
tract infection. Uncommon (may affect up to 1 in 100 people):</h2>
<h2 id="heart-attack">heart attack</h2>
<h2 id="bleeding-in-the-gut">bleeding in the gut</h2>
<h2
id="changes-in-the-blood-cell-count-which-may-result-in-bleeding-abnormal-liver-function-tests">changes
in the blood cell count which may result in bleeding, abnormal liver
function tests</h2>
<h2 id="convulsions">convulsions</h2>
<h2 id="feeling-agitated">feeling agitated</h2>
<h2 id="psychotic-symptoms">psychotic symptoms</h2>
<h2 id="colitis-inflammation-of-the-colon">colitis (inflammation of the
colon)</h2>
<h2
id="discolourations-other-than-urine-eg-skin-nail-hair-sweat">discolourations
other than urine (e.g. skin, nail, hair, sweat)</h2>
<h2 id="swallowing-difficulties">swallowing difficulties</h2>
<h2
id="inability-to-urinate-not-known-frequency-cannot-be-estimated-from-the-available-data-craving-for-large-doses-of-levodopacarbidopaentacapone-orion-in-excess-of-that-required-to-control-motor-symptoms-known-as-dopamine-dysregulation-syndrome-some-patients-experience-severe-abnormal-involuntary-movements-dyskinesias-mood-swings-or-other-side-effects-after-taking-large-doses-of-levodopacarbidopaentacapone-orion-the-following-side-effects-have-also-been-reported">inability
to urinate. Not known (frequency cannot be estimated from the available
data): Craving for large doses of Levodopa/Carbidopa/Entacapone Orion in
excess of that required to control motor symptoms, known as dopamine
dysregulation syndrome. Some patients experience severe abnormal
involuntary movements (dyskinesias), mood swings or other side effects
after taking large doses of Levodopa/Carbidopa/Entacapone Orion. The
following side effects have also been reported:</h2>
<h2 id="hepatitis-inflammation-of-the-liver">hepatitis (inflammation of
the liver)</h2>
<h2 id="itching-you-may-experience-the-following-side-effects">itching.
You may experience the following side effects:</h2>
<h2
id="inability-to-resist-the-impulse-to-perform-an-action-that-could-be-harmful-which-may-include">Inability
to resist the impulse to perform an action that could be harmful, which
may include:</h2>
<h2
id="strong-impulse-to-gamble-excessively-despite-serious-personal-or-family-consequences">strong
impulse to gamble excessively despite serious personal or family
consequences</h2>
<h2
id="altered-or-increased-sexual-interest-and-behaviour-of-significant-concern-to-you-or-to-others-for-example-an-increased-sexual-drive">altered
or increased sexual interest and behaviour of significant concern to you
or to others, for example, an increased sexual drive</h2>
<h2 id="uncontrollable-excessive-shopping-or-spending">uncontrollable
excessive shopping or spending</h2>
<p>binge eating (eating large amounts of food in a short time period) or
compulsive eating (eating more food than normal and more than is needed
to satisfy your hunger). Tell your doctor if you experience any of these
behaviours; they will discuss ways of managing or reducing the symptoms.
Reporting of side effects If you get any side effects, talk to your
doctor or pharmacist. This includes any possible side effects not listed
in this leaflet. You can also report side effects directly via the
national reporting system listed in Appendix V. By reporting side
effects you can help provide more information on the safety of this
medicine.</p>
 </div>"""      
        
* section[=].section[+]
  * title = "5. How to store levodopacarbidopaentacapone"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store levodopacarbidopaentacapone"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. Do not use
this medicine after the expiry date which is stated on the bottle and
the carton. The expiry date refers to the last day of that month. This
medicinal product does not require any special storage conditions. Do
not throw away any medicines via wastewater or household waste. Ask your
pharmacist how to throw away medicines you no longer use. These measures
will help to protect the environment.</p>
 </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <h2 id="what-levodopacarbidopaentacapone-orion-contains">What
Levodopa/Carbidopa/Entacapone Orion contains</h2>
<h2
id="the-active-substances-of-levodopacarbidopaentacapone-orion-are-levodopa-carbidopa-and-entacapone">The
active substances of Levodopa/Carbidopa/Entacapone Orion are levodopa,
carbidopa and entacapone.</h2>
<h2
id="each-levodopacarbidopaentacapone-orion-50-mg125-mg200-mg-tablet-contains-50-mg-of-levodopa-125-mg-of-carbidopa-and-200-mg-of-entacapone">Each
Levodopa/Carbidopa/Entacapone Orion 50 mg/12.5 mg/200 mg tablet contains
50 mg of levodopa, 12.5 mg of carbidopa and 200 mg of entacapone.</h2>
<h2
id="the-other-ingredients-in-the-tablet-core-are-croscarmellose-sodium-magnesium-stearate-maize-starch-mannitol-e421-and-povidone-e1201">The
other ingredients in the tablet core are croscarmellose sodium,
magnesium stearate, maize starch, mannitol (E421) and povidone
(E1201).</h2>
<p>The ingredients in the film-coating are glycerol (85 per cent)
(E422), hypromellose, magnesium stearate, polysorbate 80, red iron oxide
(E172), sucrose, titanium dioxide (E171), and yellow iron oxide (E172).
What Levodopa/Carbidopa/Entacapone Orion looks like and contents of the
pack Levodopa/Carbidopa/Entacapone Orion 50 mg/12.5 mg/200 mg: brownish
or greyish red, round, convex unscored film-coated tablets marked with
LCE 50 on one side. Levodopa/Carbidopa/Entacapone Orion comes in six
different pack sizes (10, 30, 100, 130, 175 or tablets). Not all pack
sizes may be marketed. Marketing Authorisation Holder Orion Corporation
Orionintie 1 FI-02200 Espoo Finland Manufacturer Orion Corporation Orion
Pharma Joensuunkatu 7 FI-24100 Salo Finland For any information about
this medicine, please contact the local representative of the Marketing
Authorisation Holder. Belgi /Belgique/Belgien Orion Corporation T l/Tel:
+358 10 4Lietuva Orion Corporation Tel: +358 10 4 Orion Corporation .:
+358 10 4Luxembourg/Luxemburg Orion Corporation T l/Tel: +358 10 4 esk
republika Orion Corporation Tel: +358 10 4Magyarorsz g Orion Corporation
Tel.: +358 10 4Danmark Orion Pharma A/S Tlf: +45 8614 0Malta Orion
Corporation Tel: +358 10 4Deutschland Orion Pharma GmbH J rgen-T
pfer-Stra e 22763 Hamburg Tel: +49 40 899 689-0 Nederland Orion
Corporation Tel: +358 10 4Eesti Orion Corporation Tel: +358 10 4Norge
Orion Pharma AS Tlf: +47 40 00 42<br />
Orion Corporation : +358 10 4 sterreich Orion Corporation Tel: +358 10
4Espa a Orion Corporation Tel: +358 10 4Polska Orion Pharma Poland Sp
z.o.o. Tel.: + 48 22 8333France Orion Corporation T l: +358 10 4Portugal
Orion Corporation Tel: +358 10 4Hrvatska Orion Corporation Tel.: +358 10
4Rom nia Orion Corporation Tel: +358 10 4Ireland Orion Corporation Tel:
+358 10 4Slovenija Orion Corporation Tel: +358 10 4 sland Vistor hf. S
mi: +354 535 7Slovensk republika Orion Corporation Tel: +358 10 4Italia
Orion Corporation Tel: +358 10 4Suomi/Finland Orion Corporation
Puh./Tel: +358 10 4 Orion Corporation : +358 10 4Sverige Orion Pharma AB
Tel: +46 8 623 6Latvija Orion Corporation Tel: +358 10 4United Kingdom
(Northern Ireland) Orion Corporation Tel: +358 10 4This leaflet was last
revised in Other sources of information Detailed information on this
medicine is available on the European Medicines Agency web site:</p>
 </div>"""      





                    
Instance: bundlepackageleaflet-en-d95102bde9e6478e73d009f96eccf149
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for levodopacarbidopaentacapone Package Leaflet for language en"
Description: "ePI document Bundle for levodopacarbidopaentacapone Package Leaflet for language en"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-d95102bde9e6478e73d009f96eccf149"
* entry[0].resource = composition-en-d95102bde9e6478e73d009f96eccf149

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mpd95102bde9e6478e73d009f96eccf149"
* entry[=].resource = mpd95102bde9e6478e73d009f96eccf149
                            
                    



Instance: mpd95102bde9e6478e73d009f96eccf149
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product Levodopa/Carbidopa/Entacapone Orion 50 mg/12.5 mg/200 mg film-coated tablets"
Description: "Levodopa/Carbidopa/Entacapone Orion 50 mg/12.5 mg/200 mg film-coated tablets"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/11/706/001-006"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"



* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"

* name
  * productName = "Levodopa/Carbidopa/Entacapone Orion 50 mg/12.5 mg/200 mg film-coated tablets"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#EU "EU"
    * jurisdiction = urn:iso:std:iso:3166#EU "EU"
    * language = urn:ietf:bcp:47#en  "en"



RuleSet: d95102bde9e6478e73d009f96eccf149ListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "levodopacarbidopaentacapone"

* status = #current
* mode = #working

* title = "List of all ePIs associated with levodopacarbidopaentacapone"

* subject = Reference(mpd95102bde9e6478e73d009f96eccf149)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#levodopacarbidopaentacapone "levodopacarbidopaentacapone"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry[+]
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-d95102bde9e6478e73d009f96eccf149) // levodopacarbidopaent en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"




Instance: List-d95102bde9e6478e73d009f96eccf149
InstanceOf: List
Description: "ePI document List for levodopacarbidopaentacapone Package Leaflets"

* insert d95102bde9e6478e73d009f96eccf149ListRuleset
    